We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Polynesian-specific SLC22A3 variant associates with low plasma lipoprotein(a) concentrations independent of apo(a) isoform size in males.
- Authors
Wang, Qian; McCormick, Sally; Leask, Megan P.; Watson, Huti; O'Sullivan, Conor; Krebs, Jeremy D.; Hall, Rosemary; Whitfield, Patricia; Merry, Troy L.; Murphy, Rinki; Shepherd, Peter R.
- Abstract
Lipoprotein(a) (Lp(a)) is a low-density lipoprotein (LDL)-like particle in which the apolipoprotein B component is covalently linked to apolipoprotein(a) (apo(a)). Lp(a) is a well-established independent risk factor for cardiovascular diseases. Plasma Lp(a) concentrations vary enormously between individuals and ethnic groups. Several nucleotide polymorphisms in the SLC22A3 gene associate with Lp(a) concentration in people of different ethnicities. We investigated the association of a Polynesian-specific (M¯ aori and Pacific peoples) SLC22A3 gene coding variant p.Thr44Met) with the plasma concentration of Lp(a) in a cohort of 302 healthy Polynesian males. An apo(a)-size independent assay assessed plasma Lp(a) concentrations; all other lipid and apolipoprotein concentrations were measured using standard laboratory techniques. Quantitative real-time polymerase chain reaction was used to determine apo(a) isoforms. The range of metabolic (HbA1c, blood pressure, and blood lipids) and blood lipid variables were similar between the non-carriers and carriers in age, ethnicity and BMI adjusted models. However, rs8187715 SLC22A3 variant was significantly associated with lower Lp(a) concentrations. Median Lp(a) concentration was 10.60 nmol/L (IQR: 5.40--41.00) in non-carrier group, and was 7.60 nmol/L (IQR: 5.50--12.10) in variant carrier group (P<0.05). Lp(a) concentration inversely correlated with apo(a) isoform size. After correction for apo(a) isoform size, metabolic parameters and ethnicity, the association between the SLC22A3 variant and plasma Lp(a) concentration remained. The present study is the first to identify the association of this gene variant and low plasma Lp(a) concentrations. This provides evidence for better guidance on ethnic specific cut-offs when defining 'elevated' and 'normal' plasma Lp(a) concentrations in clinical applications.
- Subjects
LIPOPROTEIN A; BLOOD lipids; APOLIPOPROTEIN B; DISEASE risk factors; GENETIC variation; POLYMERASE chain reaction
- Publication
Bioscience Reports, 2024, Vol 44, Issue 7, p1
- ISSN
0144-8463
- Publication type
Article
- DOI
10.1042/BSR20240403